Ucb Sa Stock Market Value
| UCBJF Stock | USD 174.00 0.00 0.00% |
| Symbol | UCB |
UCB SA 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to UCB SA's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of UCB SA.
| 07/20/2023 |
| 12/11/2024 |
If you would invest 0.00 in UCB SA on July 20, 2023 and sell it all today you would earn a total of 0.00 from holding UCB SA or generate 0.0% return on investment in UCB SA over 510 days. UCB SA is related to or competes with Bolt Biotherapeutics, Cara Therapeutic, Arcus Biosciences, Senti Biosciences, Cadrenal Therapeutics,, Foghorn Therapeutics, and Quoin Pharmaceuticals. UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases More
UCB SA Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure UCB SA's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess UCB SA upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.10) | |||
| Maximum Drawdown | 15.99 |
UCB SA Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for UCB SA's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as UCB SA's standard deviation. In reality, there are many statistical measures that can use UCB SA historical prices to predict the future UCB SA's volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.05) | |||
| Total Risk Alpha | (0.27) | |||
| Treynor Ratio | (0.30) |
UCB SA Backtested Returns
UCB SA retains Efficiency (Sharpe Ratio) of -0.0186, which indicates the company had a -0.0186% return per unit of volatility over the last 3 months. UCB SA exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate UCB SA's Information Ratio of (0.10), mean deviation of 0.3231, and Market Risk Adjusted Performance of (0.29) to confirm the risk estimate we provide. The firm owns a Beta (Systematic Risk) of 0.12, which indicates not very significant fluctuations relative to the market. As returns on the market increase, UCB SA's returns are expected to increase less than the market. However, during the bear market, the loss of holding UCB SA is expected to be smaller as well. At this point, UCB SA has a negative expected return of -0.0285%. Please make sure to validate UCB SA's variance, as well as the relationship between the maximum drawdown and rate of daily change , to decide if UCB SA performance from the past will be repeated in the future.
Auto-correlation | -0.01 |
Very weak reverse predictability
UCB SA has very weak reverse predictability. Overlapping area represents the amount of predictability between UCB SA time series from 20th of July 2023 to 31st of March 2024 and 31st of March 2024 to 11th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of UCB SA price movement. The serial correlation of -0.01 indicates that just 1.0% of current UCB SA price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.01 | |
| Spearman Rank Test | -0.43 | |
| Residual Average | 0.0 | |
| Price Variance | 7.49 |
UCB SA lagged returns against current returns
Autocorrelation, which is UCB SA pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting UCB SA's pink sheet expected returns. We can calculate the autocorrelation of UCB SA returns to help us make a trade decision. For example, suppose you find that UCB SA has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
UCB SA regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If UCB SA pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if UCB SA pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in UCB SA pink sheet over time.
Current vs Lagged Prices |
| Timeline |
UCB SA Lagged Returns
When evaluating UCB SA's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of UCB SA pink sheet have on its future price. UCB SA autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, UCB SA autocorrelation shows the relationship between UCB SA pink sheet current value and its past values and can show if there is a momentum factor associated with investing in UCB SA.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in UCB Pink Sheet
UCB SA financial ratios help investors to determine whether UCB Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in UCB with respect to the benefits of owning UCB SA security.